QUESTIONS / BENEFITS AND RISKS
What does a treatment decision need beyond a study?
A decision needs evidence about the particular problem and the person's health risks. Your doctor can compare the study's findings with your symptoms, illnesses, and medicines.
Changes hunger, digestion, and high blood sugar
How does semaglutide act? The medicine imitates GLP-1, a hormone that sends messages from the gut after eating. GLP-1 is normally released as the body responds to food. Semaglutide reduces high blood sugar, delays food leaving the stomach, and helps people feel full. Large studies measured weight and counted serious problems involving kidneys and the heart [2][3][4].
Those findings can't replace an assessment of your own symptoms.
Names the different people in the semaglutide trials
Who was tested in the semaglutide studies? The weight trial enrolled adults with excess weight who did not have diabetes. Participants in the heart trial had both established heart disease and excess weight. In the kidney trial, participants had both type 2 diabetes and long-standing kidney disease [2][3][4]. Approved uses differ between products and countries.
Your doctor needs to check which use applies to the proposed medicine.
Connects hunger effects with studies of actual weight loss
What explains the interest in semaglutide for weight? The medicine imitates GLP-1, a gut hormone whose messages affect hunger and fullness. Semaglutide also keeps food in the stomach longer. Tests in animals found changes in brain areas controlling eating [6]. Studies in people then measured actual changes in weight [1][4].
The animal work doesn't show how much weight one person would lose.
Reports early skin and hair findings without proving age reversal
What has GHK-Cu research examined? Researchers studied collagen, the protein giving skin strength, and other processes involved in repairing skin. Small human studies found changes in skin appearance or hair counts with the products tested [8][10][11]. Products containing several ingredients make the contribution of GHK-Cu harder to establish.
Your cream may differ, and these findings don't prove a person becomes younger.
Distinguishes GHK from GHK holding copper
What changes when copper is added? GHK has three amino acids, small substances from which the body makes proteins. When GHK holds copper, the substance is called GHK-Cu and acts differently. Much of the skin research concerns that copper-containing form [8][11]. A shortened name may conceal the difference.
The study and your product need to concern the same ingredient.
Leaves longer life and a younger body unproved
Do skin findings establish that GHK-Cu reverses aging? The research does not prove longer life or that a person becomes younger. Reviews cover cell repair and small studies of products used on skin. Skin's outer surface may prevent much of the ingredient from entering [8][9][11].
Even fewer wrinkles would not establish wider health benefits from your cream.
Separates NAD+ blood results from changes people could notice
What did NAD+ supplement trials measure? The studies mostly gave NMN or NR, ingredients the body uses to produce NAD+. Researchers tested NAD+ in blood, walking distance, reported daily life, and muscle response to insulin [14][15][17]. Insulin is a hormone that helps cells draw sugar from blood.
Broad health benefits remain uncertain in a review [13]; more blood NAD+ alone doesn't show them.
Keeps short-term supplement safety separate from years of use
What remains uncertain about NAD+ products? Lasting benefits have not been shown, and different products need separate evidence. Brief trials found acceptable safety for swallowed NMN and NR among the people tested [14][17]. The body uses those ingredients to make NAD+, rather than receiving NAD+ directly.
Your doctor cannot use those trials to establish years of safety or safe treatment into a vein.
Leaves daily use and weight-gain claims without firm answers
Have studies settled daily safety or weight gain? Researchers tested particular NAD+-related supplements for short periods, with limited broader human evidence [13][14][17]. These papers do not show NAD+ as a cause of weight gain. Nor can they establish lasting safety for every product.
Your health history and the exact product matter; a missing finding doesn't show harmlessness.
Names the women covered by the PT-141 approved use
Who is PT-141 meant to help? The name refers to bremelanotide, a medicine acting through the brain on sexual desire. Approval concerns women before menopause distressed by lasting low desire [19][22]. Menopause is when a woman's monthly periods have ended.
That approval doesn't cover men or other sexual problems.
Distinguishes PT-141 desire findings from brain scans
What improved in the bremelanotide studies? Women before menopause with distressing low desire reported more interest and less distress than women receiving placebo [20]. The placebo group received treatment without an active drug. Another study measured changed brain activity while women viewed material intended to stir sexual interest [19].
A scan alone can't show an improvement that you could notice in daily life.
Limits PT-141 use because of blood pressure and heart disease
What limits bremelanotide's approved use? Approval concerns women before menopause whose formerly normal desire became low and distressing [22]. The problem occurs across partners, activities, and settings. Longer testing commonly found nausea, headache, and flushing, a hot and reddened face [21].
The medicine can briefly raise blood pressure. The label excludes uncontrolled high blood pressure and diagnosed heart or blood-vessel disease [22].